Malignant melanoma of eye (disorder)
SUAVE: A randomised phase II study of sunitinib versus dacarbazine in the treatment of patients with metastatic uveal melanoma
Year Started: 2010
Samples collected for future research during the SUAVE clinical trial.
- Access:
- Open to applicants
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
-
Commercial restriction, Outside EU access restriction, Xenograft restriction
Associated Data Type |
Procurement Timeframe |
There is no associated data for this collection. |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
|
Not applicable |
26 - 50% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Serum |
|
-60°C to -85°C |
|
Not applicable |
26 - 50% |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
|
Not applicable |
51 - 75% |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Serum |
|
-60°C to -85°C |
|
Not applicable |
51 - 75% |